Evidence map›Paper›PMID 42301560›Full record

ArticleDiscover oncology2026

A rare case of angiosarcoma of the ureter.

A P Goncharov, G Kharaishvili, A N Goldin, E Ben Aharon, C Dicussari Elisaeou, A Ushman, J Olejko, S Nicolaides, P Stavrou, N M Azoulay Engelhard and 14 more

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

A P Goncharov *Department of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
G Kharaishvili *Faculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
A N GoldinFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
E Ben AharonFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
C Dicussari ElisaeouDepartment of Oncology, German Medical Institute, 4108, Limassol, Cyprus.
A UshmanFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
J OlejkoFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
S NicolaidesFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
P StavrouFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
N M Azoulay EngelhardFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
R ShimonyFaculty of Medical and Health Sciences, Tel Aviv University, 6997801, Tel Aviv, Israel.
M OsikaDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
A LangerDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
M BartouškováDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
N BodnarováDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
D VitáskováDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
M SpisarováDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
M MarhefkaDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
H ŠtudentováDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
B MelicharDepartment of Oncology, University Hospital, Olomouc, 779 00, Czech Republic.
F HruškaFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
I HartmannFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
G HorňákFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic.
D SkanderováFaculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, 779 00, Czech Republic. Daniela.skanderova@fnol.cz.

Funding

FNOL 00098892Ministerstvo Zdravotnictví Ceské Republiky NU20-03-00201
6 · The paper itself

Abstract

backgroundPrimary angiosarcoma of the urinary system is a rare, aggressive endothelial malignancy, with only 113 cases of renal angiosarcoma documented as of 2023. Angiosarcoma of the ureter is a much less common condition. Clinical manifestations commonly include flank pain, hematuria, an abdominal mass, weight loss, fatigue, and dizziness. In rare instances, spontaneous tumour rupture may result in retroperitoneal haemorrhage. Management primarily involves surgical resection, often complemented by adjuvant radiation therapy and chemotherapy. An 88-year-old patient was admitted to the hospital due to weight loss, urine retention and macroscopic hematuria. Initial evaluation with US and CT urography found a tumorous lesion in the pelvic part of the right ureter. PET/CT confirms a hypermetabolic enhancing lesion of the right ureter, with no metastatic lymph nodes or evidence of distant metastases. The patient was indicated for a laparoscopic right-sided nephroureterectomy, and the surgery was completed without complications. Histopathological evaluation confirmed the diagnosis of angiosarcoma, which was classified as grade II according to the FNCLCC classification and staged as pT3N0M0. A month after the surgery, the patient was bleeding from the right internal iliac artery. Embolisation was performed, and stent grafts were inserted. A few days later, the patient died from sepsis.

conclusionAngiosarcoma within the urinary system is rare. To date, only three cases of angiosarcoma of the ureter have been reported. Cases of angiosarcoma originating in the urinary bladder, kidney or other retroperitoneal structures were reported more frequently. Surgical intervention is the principal therapeutic option, followed by adjuvant therapy. Establishing standardised diagnostic and treatment protocols is crucial to improving patient outcomes, but at this moment, case reports are the only source of information on clinical management.

Indexed as

AngiosarcomaCase reportFNCLCC classificationNephroureterectomySoft tissue tumoursUreter angiosarcoma

Identifiers

PMID42301560
PMCPMC13504048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.